Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
Rades
Dirk
D
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D015687:Cell Hypoxia; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000150:complications* / Q000532:radiotherapy; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin